Epidemiology of Dementia: the MoVIES Project Alzheimer’s Disease Patient Registry (ADPR ), University of Pittsburgh Initially funded by NIA 1987-1989 under.

Slides:

Advertisements

Similar presentations

Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimers Disease Drug: COMET-AD.

Advertisements

Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.

Department of Neurology, Mayo Clinic Arizona

Supported by grants from: National Human Genome Research Institute (ELSI) HG/AG (The REVEAL Study); National Institute on Aging AG (The MIRAGE.

Medium-term prognosis of an incident cohort of people with Parkinson’s and their carers vs a community-based control group Carl Counsell.

Designing Clinical Research Studies An overview S.F. O’Brien.

Cognitive Impairment in Patients Admitted to the Inpatient Unit: do we screen patients for it? Dr Clare Kendall Dr Rebecca Bhatia St Peter’s Hospice, Bristol.

New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.

Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.

DRAFT Promotional Copy for NNSDO 1 Cognitive / Mental Status Assessment of Older Adults.

PRACTICE PARAMETER: RISK OF DRIVING AND ALZHEIMER ’ S DISEASE (AN EVIDENCE-BASED REVIEW) Richard M. Dubinsky, MD; Anthony C. Stein, PhD; and Kelly Lyons,

Neuropathology and Cognitive Scores Workgroup The role of vascular and Alzheimer’s Disease pathology in differential cognitive impairment among older adults.

Assessment/Enhancement of Cognitive Ability in Older Adults Karlene Ball Center for Research on Applied Gerontology University of Alabama at Birmingham.

Tony WAEGEMANS, MD UCB Pharma, Belgium. TW/ll/ Washington/MCI 2 MCI as implemented in our study MCI is a very early stage of dementia with as main.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2008.

The Prevalence of Mental Illness

Journal Club Alcohol and Health: Current Evidence January-February 2005.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.

The New Brief Cognitive Assessment Tool (BCAT): The Role of Cognitive Assessment in Improving Health Outcomes Dr. William Mansbach October 25, 2011.

Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.

Health Economics and Technology Assessment Research Centre Katalin Érsek 1, Krisztián Kárpáti 1, Tibor Kovács 2, László Gulácsi.

Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.

Experimental Study.

MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.

Attrition and its effects – example from analysis of the MRC cognitive function and aging study Fiona Matthews MRC Biostatistics Unit.

ACTIVE Design Sites, Sampling, Replicates, and Follow-up.

Nikki Jandt Denise Halbach Tearanie VanBoxel Life Cycle Nutrition

A STUDY OF RURAL CHILDHOOD OBESITY Dr. Marilyn Duran PhD, RN Department of Nursing Tarleton State University.

Screening for Stroke and Cognitive Impairment Chapter 2: Background.

SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.

Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.

Community Partnerships Make a Difference: Free Cancer Clinics in Wyoming County Cheryl McGovern, Valerie Bell, Regina Allen Partnership History The Wyoming.

Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimer’s Disease Drugs: COMET-AD.

Tuberculosis Prevalence, Screening and Treatment among Filipinos in Union City, California Christine Araneta PA-C, Stephanie Sario BA, Jennifer Lee MPH.

1 Lecture 2 Screening and diagnostic tests Normal and abnormal Validity: “gold” or criterion standard Sensitivity, specificity, predictive value Likelihood.

Yaffe K, Laffan AM, et al. Sleep-disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women. JAMA.2011;306(6):

CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:

Are There Sex Differences in sociodemographic background and cognitive Functions Among Patients With dementia,a comparative study among an Egyptian sample.

Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.

1 Patient Dependence, Function, and Changes in Cost of Care in Alzheimer’s Disease Carolyn W. Zhu JJP VA Medical Center, Mount Sinai School of Medicine.

Obtaining housing associated with achieving abstinence after detoxification in adults with addiction Tae Woo Park, Christine Maynié-François, Richard Saitz.

Procedures Manual, Control Series, & Phenotype Committee Update Stephanie Doan, MPH NIA AD Genetics Initiative Co-Coordinator Columbia University.

Meredith Cook – PharmD Candidate Mercer University COPHS August, 2012 Cognitive Trajectories after Postoperative Delirium.

Why Physicians Do Not Diagnose Alzheimer’s Disease Mark A. Sager, MD Professor of Medicine and Population Health Sciences Director, Wisconsin Alzheimer’s.

Detecting Individual Differences in Changes in Memory Functioning Dr. Len Lecci Professor of Psychology University of North Carolina Wilmington Director.

Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.

Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.

MCI Conversion to Dementia: Clinic and Community-Based Studies

Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.

PZP: A novel biomarker for early Alzheimer’s disease ? Diana A.T. Nijholt Department of Neurology Laboratory for Clinical and Cancer Proteomics

Case-Control Studies Abdualziz BinSaeed. Case-Control Studies Type of analytic study Unit of observation and analysis: Individual (not group)

Psychosis in Dementia Conclusions Psychosis in dementia is distressful and disturbing to patients and  Is similar across the spectrum of the dementia.

Analytical Studies Case – Control Studies By Dr. Sameh Zaytoun (MBBch, DPH, DM, FRCP(Manch), DTM&H(UK),Dr.PH) University of Alexandria - Egypt Consultant.

Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.

Copyright © 2008 Delmar. All rights reserved. Chapter 4 Epidemiology and Public Health Nursing.

DIABETES AS A RISK FACTOR FOR COGNITIVE DECLINE IN OLDER PATIENTS F. Limongi, A. Marseglia, S. Maggi, M. Noale, G. Romanato, P. Siviero, G. Crepaldi CNR,

Results Results Dillon C, MD, PhD; Vazquez G, MD, PhD ; Corrales A, MD; Allegri RF, MD, PhD; Taragano FE, MD, PhD. CEMIC University Hospital, SIREN, Department.

Table 1. Methodological Evaluation of Observational Research (MORE) – observational studies of incidence or prevalence of chronic diseases Tatyana Shamliyan.

Requirements to run clinical trials: Research fee calculation, patient consent Kyoung Hwa Ha.

Aka STEEL VALLEY SENIORS SURVEY (SVSS)

M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²

CERAD immediate memory verbal fluency (animals)

Present: Disease Past: Exposure

Epidemiology of Dementia: the MoVIES Project

פסיכוגריאטריה ד''ר שורצמן בי''ח פלימן.

From the Indianapolis – Ibadan Dementia Research Project.

Excessive Daytime Sleepiness & Depression

SYNOPSIS OF THE PROTOCOL

Presentation transcript:

Epidemiology of Dementia: the MoVIES Project Alzheimer’s Disease Patient Registry (ADPR ), University of Pittsburgh Initially funded by NIA under cooperative agreement, U01 AG06782: Population-based Dementia Registry: Subsequently funded by NIA as project grant R01, AG07562, Epidemiology of Dementia: A Prospective Community Study. Locally called “Monongahela Valley Independent Elders Survey” (MoVIES). Home

MoVIES Project Site: mid- Monongahela Valley in Washington and Westmoreland counties, Southwestern Pennsylvania; 23 communities served by the 23 Mon Valley communities served by the Mon Valley Community Health Center, Monessen, PA. Rural area with small towns, former home to coal mines and steel mills until the 1970s. Home

MoVIES Cohort Random sample, N=1422 1:13 age-stratified (65-74, 75+ years) random sample drawn from Voter Registration lists for the selected communities. Volunteer sample, N=259 drawn from same area, meeting same entry criteria. Home

MoVIES Entry Criteria Age 65+ at time of recruitment; Mon Valley resident; Not in nursing home at time of recruitment; Fluent in English; At least Grade 6 education. Home

MoVIES Cohort Characteristics Total sample size of original cohort: –N=1681 (random plus volunteer) Age: Mean (SD) = 72.6 (5.7) yrs (baseline) Sex ratio: F:M=55.5 : 45 Education: % < high school graduate: 43.3% Home

MoVIES:Overview Sample recruited as part of ADPR; prevalent cases identified. Began prospective followup in 1989; Subjects re-assessed approximately every two years; incident cases identified. Followup completed in Home

MoVIES Screening Cognitive Tests MMSE CERAD Word List (10) Learning (3 trials) Delayed Recall Delayed Recognition (originals and foils) Story Immediate Recall Delayed Recall Boston Naming (15) Word Fluency P&S Fruits & Animals CERAD Praxis (4) Clock Drawing Trailmaking A Trailmaking B Temporal Orientation Home

MoVIES:Study procedures At each wave: All consenting survivors: cognitive screening and risk factor assessment. Screening identifies those who are –(a) cognitively “impaired;” –(b) cognitively “declined.” Impaired and declined subjects undergo clinical diagnostic evaluation for dementia. Home

MoVIES Screening Criteria (1) Cognitive impairment: Actual scores, at any given time, at or below the 10 th %ile of the sample on: MMSE and/or At least one memory test and one other test. Home

MoVIES Screening Criteria (2) Cognitive Decline: Decline over time in scores  To “impaired” levels, and/or  By amounts greater than or equal to that experienced by 95 % of the cohort on MMSE and/or At least two other tests. Home

MoVIES Clinical Evaluation (1) In-home evaluation; History and general physical exam; Detailed neurological exam; Brief mental status exam; Psychiatric exam; Blood: chemistry/hematology/serology; Home

MoVIES Clinical Evaluation (2) Based on Pittsburgh ADRC/CERAD assessment protocols, modified for field use; DSM-III-R criteria for dementia; CDR rating for stage/severity; NINCDS-ADRDA criteria for Probable and Possible AD. Home